SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Edison Oncology at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

Edison Oncology brings 3 presentations to SNO 2026 in Philadelphia. Edison Oncology's program centres on EO1001, an oral brain-penetrating pan-ErbB inhibitor, including updated early trial results. Preclinical work on a second agent in tumor models also features.

OrganizationSNO 2026 Attendance
Edison Oncology
Menlo Park, CA
Biotech
A clinical-stage biopharmaceutical company developing biomarker-driven cancer therapies, including brain-penetrant candidates for brain tumors.
Poster
Fri Nov 13
7:30–9:30pm
Poster
Fri Nov 13
7:30–9:30pm

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Edison Oncology

Tell us what you sell and we’ll find the people at Edison Oncology most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction